Boenning & Scattergood Inc. Increases Position in Danaher Co. (DHR)

Boenning & Scattergood Inc. boosted its position in shares of Danaher Co. (NYSE:DHR) by 2.8% in the first quarter, Holdings Channel reports. The institutional investor owned 14,745 shares of the conglomerate’s stock after acquiring an additional 401 shares during the period. Boenning & Scattergood Inc.’s holdings in Danaher were worth $1,947,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently made changes to their positions in DHR. Cambridge Trust Co. raised its position in Danaher by 1.3% during the first quarter. Cambridge Trust Co. now owns 159,709 shares of the conglomerate’s stock valued at $21,085,000 after purchasing an additional 2,071 shares during the period. Clear Harbor Asset Management LLC raised its position in Danaher by 5.0% during the first quarter. Clear Harbor Asset Management LLC now owns 3,956 shares of the conglomerate’s stock valued at $522,000 after purchasing an additional 190 shares during the period. BLB&B Advisors LLC raised its position in Danaher by 9.7% during the first quarter. BLB&B Advisors LLC now owns 37,613 shares of the conglomerate’s stock valued at $4,966,000 after purchasing an additional 3,320 shares during the period. Financial Gravity Wealth Inc. purchased a new stake in Danaher during the first quarter valued at approximately $175,000. Finally, Watch Point Trust Co raised its position in Danaher by 10.3% during the first quarter. Watch Point Trust Co now owns 24,308 shares of the conglomerate’s stock valued at $3,210,000 after purchasing an additional 2,271 shares during the period. 77.59% of the stock is owned by institutional investors.

In other news, SVP Angela S. Lalor sold 4,534 shares of the stock in a transaction that occurred on Wednesday, February 27th. The stock was sold at an average price of $127.25, for a total value of $576,951.50. Following the sale, the senior vice president now directly owns 21,209 shares in the company, valued at $2,698,845.25. The sale was disclosed in a document filed with the SEC, which is available at this link. Also, Director Walter G. Lohr sold 10,578 shares of the stock in a transaction that occurred on Wednesday, February 27th. The stock was sold at an average price of $126.85, for a total value of $1,341,819.30. Following the completion of the sale, the director now owns 20,691 shares in the company, valued at $2,624,653.35. The disclosure for this sale can be found here. Over the last quarter, insiders sold 183,150 shares of company stock worth $23,279,637. Company insiders own 11.40% of the company’s stock.

A number of brokerages have issued reports on DHR. Zacks Investment Research upgraded Danaher from a “hold” rating to a “buy” rating and set a $147.00 price objective on the stock in a research report on Tuesday, April 9th. Needham & Company LLC restated a “buy” rating and set a $141.00 price objective (up from $138.00) on shares of Danaher in a research report on Wednesday, April 17th. Jefferies Financial Group upped their price objective on Danaher to $140.00 and gave the company a “buy” rating in a research report on Tuesday, February 26th. Deutsche Bank upped their price objective on Danaher to $130.00 and gave the company a “buy” rating in a research report on Tuesday, February 26th. Finally, Janney Montgomery Scott upped their price objective on Danaher from $136.00 to $174.00 and gave the company a “buy” rating in a research report on Wednesday, April 17th. One equities research analyst has rated the stock with a hold rating and twelve have given a buy rating to the company’s stock. The stock presently has an average rating of “Buy” and an average price target of $131.75.

Shares of NYSE DHR traded down $0.25 during midday trading on Monday, hitting $126.52. The company’s stock had a trading volume of 42,300 shares, compared to its average volume of 2,635,838. The company has a debt-to-equity ratio of 0.34, a quick ratio of 1.07 and a current ratio of 1.47. Danaher Co. has a 12-month low of $94.59 and a 12-month high of $134.50. The company has a market cap of $90.73 billion, a price-to-earnings ratio of 28.03, a PEG ratio of 2.32 and a beta of 1.04.

Danaher (NYSE:DHR) last issued its quarterly earnings results on Thursday, April 18th. The conglomerate reported $1.07 earnings per share for the quarter, topping the consensus estimate of $1.01 by $0.06. Danaher had a return on equity of 11.85% and a net margin of 12.04%. The firm had revenue of $4.88 billion for the quarter, compared to the consensus estimate of $4.80 billion. During the same period in the prior year, the business posted $0.99 earnings per share. The company’s revenue for the quarter was up 3.9% on a year-over-year basis. Sell-side analysts predict that Danaher Co. will post 4.78 earnings per share for the current year.

The firm also recently declared a quarterly dividend, which will be paid on Friday, April 26th. Stockholders of record on Friday, March 29th will be issued a $0.17 dividend. This represents a $0.68 annualized dividend and a dividend yield of 0.54%. This is an increase from Danaher’s previous quarterly dividend of $0.16. The ex-dividend date is Thursday, March 28th. Danaher’s dividend payout ratio is presently 15.04%.

ILLEGAL ACTIVITY NOTICE: “Boenning & Scattergood Inc. Increases Position in Danaher Co. (DHR)” was first posted by Baseball Daily News and is the sole property of of Baseball Daily News. If you are reading this article on another publication, it was illegally copied and reposted in violation of US & international trademark and copyright legislation. The legal version of this article can be viewed at https://www.baseballdailydigest.com/news/2019/04/22/boenning-scattergood-inc-increases-position-in-danaher-co-dhr.html.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company's Life Sciences segment provides mass spectrometers; cellular analysis, lab automation, and centrifugation instruments; microscopes; and genomics consumables.

Read More: How Does the Quiet Period Work?

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHR).

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.